54 results on '"Abramovitch RB"'
Search Results
2. Targeting Mycobacterium tuberculosis pH-driven adaptation.
- Author
-
Dechow SJ and Abramovitch RB
- Subjects
- Hydrogen-Ion Concentration, Animals, Humans, Macrophages microbiology, Virulence, Gene Expression Regulation, Bacterial, Bacterial Proteins metabolism, Bacterial Proteins genetics, Antitubercular Agents pharmacology, Mycobacterium tuberculosis genetics, Mycobacterium tuberculosis metabolism, Mycobacterium tuberculosis drug effects, Mycobacterium tuberculosis growth & development, Mycobacterium tuberculosis physiology, Adaptation, Physiological, Tuberculosis microbiology, Tuberculosis drug therapy
- Abstract
Mycobacterium tuberculosis (Mtb) senses and adapts to host environmental cues as part of its pathogenesis. One important cue sensed by Mtb is the acidic pH of its host niche - the macrophage. Acidic pH induces widespread transcriptional and metabolic remodelling in Mtb. These adaptations to acidic pH can lead Mtb to slow its growth and promote pathogenesis and antibiotic tolerance. Mutants defective in pH-dependent adaptations exhibit reduced virulence in macrophages and animal infection models, suggesting that chemically targeting these pH-dependent pathways may have therapeutic potential. In this review, we discuss mechanisms by which Mtb regulates its growth and metabolism at acidic pH. Additionally, we consider the therapeutic potential of disrupting pH-driven adaptations in Mtb and review the growing class of compounds that exhibit pH-dependent activity or target pathways important for adaptation to acidic pH.
- Published
- 2024
- Full Text
- View/download PDF
3. The Mycobacterium tuberculosis MmpL3 inhibitor MSU-43085 is active in a mouse model of infection.
- Author
-
Williams JT, Giletto M, Haiderer ER, Aleiwi B, Krieger-Burke T, Ellsworth E, and Abramovitch RB
- Subjects
- Animals, Mice, Nontuberculous Mycobacteria, Mycobacterium tuberculosis, Tuberculosis drug therapy, Tuberculosis microbiology, Mycobacterium Infections, Nontuberculous microbiology
- Abstract
Importance: MmpL3 is a protein that is required for the survival of bacteria that cause tuberculosis (TB) and nontuberculous mycobacterial (NTM) infections. This report describes the discovery and characterization of a new small molecule, MSU-43085, that targets MmpL3 and is a potent inhibitor of Mycobacterium tuberculosis (Mtb) and M. abscessus survival. MSU-43085 is shown to be orally bioavailable and efficacious in an acute model of Mtb infection. However, the analog is inactive against Mtb in chronically infected mice. Pharmacokinetic and metabolite identification studies identified in vivo metabolism of MSU-43085, leading to a short half-life in treated mice. These proof-of-concept studies will guide further development of the MSU-43085 series for the treatment of TB or NTM infections., Competing Interests: R.B.A. and E.E. are owners of Tarn Biosciences, Inc., a company that is working to develop new antimycobacterial drugs. R.B.A., J.T.W., and E.E. are inventors on a patent application covering matter described in this study.
- Published
- 2024
- Full Text
- View/download PDF
4. A genetic selection for Mycobacterium smegmatis mutants tolerant to killing by sodium citrate defines a combined role for cation homeostasis and osmotic stress in cell death.
- Author
-
Williams JT, Baker JJ, Zheng H, Dechow SJ, Fallon J, Murto M, Albrecht VJ, Gilliland HN, Olive AJ, and Abramovitch RB
- Subjects
- Sodium Citrate metabolism, Osmotic Pressure, Homeostasis, Cations metabolism, Chelating Agents metabolism, Mycobacterium smegmatis metabolism, Mycobacterium tuberculosis genetics
- Abstract
Mycobacteria can colonize environments where the availability of metal ions is limited. Biological or inorganic chelators play an important role in limiting metal availability, and we developed a model to examine Mycobacterium smegmatis survival in the presence of the chelator sodium citrate. We observed that instead of restricting M. smegmatis growth, concentrated sodium citrate killed M. smegmatis . RNAseq analysis during sodium citrate treatment revealed transcriptional signatures of metal starvation and hyperosmotic stress. Notably, metal starvation and hyperosmotic stress, individually, do not kill M. smegmatis under these conditions. A forward genetic transposon selection was conducted to examine why sodium citrate was lethal, and several sodium-citrate-tolerant mutants were isolated. Based on the identity of three tolerant mutants, mgtE , treZ , and fadD6, we propose a dual stress model of killing by sodium citrate, where sodium citrate chelate metals from the cell envelope and then osmotic stress in combination with a weakened cell envelope causes cell lysis. This sodium citrate tolerance screen identified mutants in several other genes with no known function, with most conserved in the pathogen M. tuberculosis . Therefore, this model will serve as a basis to define their functions, potentially in maintaining cell wall integrity, cation homeostasis, or osmotolerance. IMPORTANCE Bacteria require mechanisms to adapt to environments with differing metal availability. When Mycobacterium smegmatis is treated with high concentrations of the metal chelator sodium citrate, the bacteria are killed. To define the mechanisms underlying killing by sodium citrate, we conducted a genetic selection and observed tolerance to killing in mutants of the mgtE magnesium transporter. Further characterization studies support a model where killing by sodium citrate is driven by a weakened cell wall and osmotic stress, that in combination cause cell lysis., Competing Interests: R.B.A. is the founder and owner of Tarn Biosciences, Inc., a company that is working to develop new antimycobacterial drugs.
- Published
- 2023
- Full Text
- View/download PDF
5. Discovery and characterization of antimycobacterial nitro-containing compounds with distinct mechanisms of action and in vivo efficacy.
- Author
-
Eke IE, Williams JT, Haiderer ER, Albrecht VJ, Murdoch HM, Abdalla BJ, and Abramovitch RB
- Subjects
- Animals, Mice, Nitro Compounds, Bacterial Load, Nitroimidazoles, Nitrofurans pharmacology
- Abstract
Nitro-containing compounds have emerged as important agents in the control of tuberculosis (TB). From a whole-cell high-throughput screen for Mycobacterium tuberculosis (Mtb) growth inhibitors, 10 nitro-containing compounds were prioritized for characterization and mechanism of action studies. HC2209, HC2210, and HC2211 are nitrofuran-based prodrugs that need the cofactor F
420 machinery for activation. Unlike pretomanid which depends only on deazaflavin-dependent nitroreductase (Ddn), these nitrofurans depend on Ddn and possibly another F420 -dependent reductase for activation. These nitrofurans also differ from pretomanid in their potent activity against Mycobacterium abscessus . Four dinitrobenzamides (HC2217, HC2226, HC2238, and HC2239) and a nitrofuran (HC2250) are proposed to be inhibitors of decaprenyl-phosphoryl-ribose 2'-epimerase 1 (DprE1), based on isolation of resistant mutations in dprE1 . Unlike other DprE1 inhibitors, HC2250 was found to be potent against non-replicating persistent bacteria, suggesting additional targets. Two of the compounds, HC2233 and HC2234, were found to have potent, sterilizing activity against replicating and non-replicating Mtb in vitro , but a proposed mechanism of action could not be defined. In a pilot in vivo efficacy study, HC2210 was orally bioavailable and efficacious in reducing bacterial load by ~1 log in a chronic murine TB infection model., Competing Interests: R.B.A. is the founder and owner of Tarn Biosciences, Inc., a company that is working to develop new antimycobacterial drugs.- Published
- 2023
- Full Text
- View/download PDF
6. Molecular Mechanisms of MmpL3 Function and Inhibition.
- Author
-
Williams JT and Abramovitch RB
- Subjects
- Bacterial Proteins metabolism, Microbial Sensitivity Tests, Anti-Bacterial Agents pharmacology, Antitubercular Agents pharmacology, Membrane Proteins metabolism, Mycobacterium tuberculosis genetics
- Abstract
Mycobacteria species include a large number of pathogenic organisms such as Mycobacterium tuberculosis , Mycobacterium leprae , and various non-tuberculous mycobacteria. Mycobacterial membrane protein large 3 (MmpL3) is an essential mycolic acid and lipid transporter required for growth and cell viability. In the last decade, numerous studies have characterized MmpL3 with respect to protein function, localization, regulation, and substrate/inhibitor interactions. This review summarizes new findings in the field and seeks to assess future areas of research in our rapidly expanding understanding of MmpL3 as a drug target. An atlas of known MmpL3 mutations that provide resistance to inhibitors is presented, which maps amino acid substitutions to specific structural domains of MmpL3. In addition, chemical features of distinct classes of Mmpl3 inhibitors are compared to provide insights into shared and unique features of varied MmpL3 inhibitors.
- Published
- 2023
- Full Text
- View/download PDF
7. ppe51 Variants Enable Growth of Mycobacterium tuberculosis at Acidic pH by Selectively Promoting Glycerol Uptake.
- Author
-
Dechow SJ, Baker JJ, Murto M, and Abramovitch RB
- Subjects
- Humans, Glycerol metabolism, Acids metabolism, Hydrogen-Ion Concentration, Carbon metabolism, Mycobacterium tuberculosis metabolism, Tuberculosis microbiology
- Abstract
In defined media supplemented with single carbon sources, Mycobacterium tuberculosis (Mtb) exhibits carbon source specific growth restriction. When supplied with glycerol as the sole carbon source at pH 5.7, Mtb establishes a metabolically active state of nonreplicating persistence known as acid growth arrest. We hypothesized that acid growth arrest on glycerol is not a metabolic restriction, but rather an adaptive response. To test this hypothesis, we selected for and identified several Mtb mutants that could grow under these restrictive conditions. All mutations were mapped to the ppe51 gene and resulted in variants with 3 different amino acid substitutions- S211R, E215K, and A228D. Expression of the ppe51 variants in Mtb promoted growth at acidic pH showing that the mutant alleles are sufficient to cause the dominant gain-of-function, Enhanced Acid Growth (EAG) phenotype. Testing growth on other single carbon sources showed the PPE51 variants specifically enhanced growth on glycerol, suggesting PPE51 plays a role in glycerol uptake. Using radiolabeled glycerol, enhanced glycerol uptake was observed in Mtb expressing the PPE51 (S211R) variant, with glycerol overaccumulation in triacylglycerol. Notably, the EAG phenotype is deleterious for growth in macrophages, where the mutants have selectively faster replication and reduced survival in activated macrophages compared to resting macrophages. Recombinant PPE51 protein exhibited differential thermostability in the wild type (WT) or S211R variants in the presence of glycerol, supporting the model that EAG substitutions alter PPE51-glycerol interactions. Together, these findings support that PPE51 variants selectively promote glycerol uptake and that slowed growth at acidic pH is an important adaptive mechanism required for macrophage pathogenesis. IMPORTANCE It is puzzling why Mycobacterium tuberculosis (Mtb) cannot grow on glycerol at acidic pH, as it has a carbon source and oxygen, everything it needs to grow. In this study, we found that Mtb limits uptake of glycerol at acidic pH to restrict its growth and that mutations in ppe51 promote uptake of glycerol at acidic pH and enable growth. That is, Mtb can grow well at acidic pH on glycerol, but has adapted instead to stop growth. Notably, ppe51 variants exhibit enhanced replication and reduced survival in activated macrophages, supporting a role for pH-dependent slowed growth during macrophage pathogenesis.
- Published
- 2022
- Full Text
- View/download PDF
8. Milk Contamination by Mycobacterium tuberculosis Complex, Implications for Public Health in Amazonas, Brazil.
- Author
-
Carneiro PAM, Pasquatti TN, Lima DAR, Rodrigues RA, Takatani H, Silva CBDG, Jardim R, Abramovitch RB, Wilkins MJ, Davila AMR, Araujo FR, and Kaneene JB
- Subjects
- Animals, Humans, Female, Cattle, Milk microbiology, Brazil, Buffaloes, Public Health, Mycobacterium tuberculosis, Tuberculosis, Tuberculosis, Bovine epidemiology
- Abstract
Abstract: In Brazil, contamination of raw milk with Mycobacterium tuberculosis complex (MTC) has been reported in several states. The highest rate of consumption of raw milk and its derivatives in Brazil occurs in Amazonas. This state also has the highest prevalence of tuberculosis in both humans and livestock. We assessed the contamination of cow's milk and buffalo's milk with MTC in Amazonas, focusing on Mycobacterium bovis, the species most commonly found in cattle and buffalo. In 2019, 250 samples of raw milk (91 from cattle, 159 from buffalo) were collected before processing from three milk plants in the state of Amazonas. The samples were placed into 21 pools and analyzed using shotgun metagenomic sequencing and taxonomic classification with Kraken 2 and MegaBLAST. To confirm the identity of mycobacterial species found, BLASTN was used to identify specific genomic positions in the TbD1 and RD1 regions and flanking RD4 region. MTC genetic material was identified in all pools of raw milk. Genetic material consistent with M. bovis was identified in seven pools of raw milk (1 from cattle, 6 from buffalo). Buffalo's milk had significantly higher MTC reads than did cow's milk. The common practice of consumption of raw milk and its derivatives in Amazonas presents a risk to public health. Urgent measures to prevent transmission of foodborne tuberculosis are needed in the Amazon region. Greater efforts and resources also should be directed toward elimination of bovine tuberculosis in cattle and buffalo herds in Amazonas and the rest of Brazil., (Copyright ©, International Association for Food Protection.)
- Published
- 2022
- Full Text
- View/download PDF
9. Response to Hypoxia and the Ensuing Dysregulation of Inflammation Impacts Mycobacterium tuberculosis Pathogenicity.
- Author
-
Bucşan AN, Veatch A, Singh DK, Akter S, Golden NA, Kirkpatrick M, Threeton B, Moodley C, Ahmed M, Doyle LA, Russell-Lodrigue K, Norton EB, Didier PJ, Roy CJ, Abramovitch RB, Mehra S, Khader SA, and Kaushal D
- Subjects
- Animals, Granuloma, Hypoxia, Inflammation pathology, Lung pathology, Macaca mulatta, Virulence, Mycobacterium tuberculosis genetics
- Abstract
Rationale: Different Mycobacterium tuberculosis ( Mtb ) strains exhibit variable degrees of virulence in humans and animal models. Differing stress response strategies used by different strains of Mtb could influence virulence. Objectives: We compared the virulence of two strains of Mtb with use in animal model research: CDC1551 and Erdman. Methods: Rhesus macaques, which develop human-like tuberculosis attributes and pathology, were infected with a high dose of either strain via aerosol, and virulence was compared by bacterial burden and pathology. Measurements and Main Results: Infection with Erdman resulted in significantly shorter times to euthanasia and higher bacterial burdens and greater systemic inflammation and lung pathology relative to those infected with CDC1551. Macaques infected with Erdman also exhibited significantly higher early inflammatory myeloid cell influx to the lung, greater macrophage and T cell activity, and higher expression of lung remodeling (extracellular matrix) genes, consistent with greater pathology. Expression of NOTCH4 (neurogenic locus notch homolog 4) signaling, which is induced in response to hypoxia and promotes undifferentiated cellular state, was also higher in Erdman-infected lungs. The granulomas generated by Erdman, and not CDC1551, infection appeared to have larger regions of necrosis, which is strongly associated with hypoxia. To better understand the mechanisms of differential hypoxia induction by these strains, we subjected both to hypoxia in vitro . Erdman induced higher concentrations of DosR regulon relative to CDC1551. The DosR regulon is the global regulator of response to hypoxia in Mtb and critical for its persistence in granulomas. Conclusions: Our results show that the response to hypoxia is a critical mediator of virulence determination in Mtb , with potential impacts on bacillary persistence, reactivation, and efficiency of therapeutics.
- Published
- 2022
- Full Text
- View/download PDF
10. Targeting tuberculosis - an interview with Robert Abramovitch.
- Author
-
Abramovitch RB
- Subjects
- Germany, History, 19th Century, Humans, Mycobacterium tuberculosis, Tuberculosis drug therapy
- Published
- 2022
- Full Text
- View/download PDF
11. Therapeutic efficacy of antimalarial drugs targeting DosRS signaling in Mycobacterium abscessus .
- Author
-
Belardinelli JM, Verma D, Li W, Avanzi C, Wiersma CJ, Williams JT, Johnson BK, Zimmerman M, Whittel N, Angala B, Wang H, Jones V, Dartois V, de Moura VCN, Gonzalez-Juarrero M, Pearce C, Schenkel AR, Malcolm KC, Nick JA, Charman SA, Wells TNC, Podell BK, Vennerstrom JL, Ordway DJ, Abramovitch RB, and Jackson M
- Subjects
- Animals, Anti-Bacterial Agents pharmacology, Anti-Bacterial Agents therapeutic use, Mice, Microbial Sensitivity Tests, Antimalarials pharmacology, Antimalarials therapeutic use, Mycobacterium Infections, Nontuberculous drug therapy, Mycobacterium Infections, Nontuberculous microbiology, Mycobacterium abscessus physiology
- Abstract
A search for alternative Mycobacterium abscessus treatments led to our interest in the two-component regulator DosRS, which, in Mycobacterium tuberculosis , is required for the bacterium to establish a state of nonreplicating, drug-tolerant persistence in response to a variety of host stresses. We show here that the genetic disruption of dosRS impairs the adaptation of M. abscessus to hypoxia, resulting in decreased bacterial survival after oxygen depletion, reduced tolerance to a number of antibiotics in vitro and in vivo, and the inhibition of biofilm formation. We determined that three antimalarial drugs or drug candidates, artemisinin, OZ277, and OZ439, can target DosS-mediated hypoxic signaling in M. abscessus and recapitulate the phenotypic effects of genetically disrupting dosS . OZ439 displayed bactericidal activity comparable to standard-of-care antibiotics in chronically infected mice, in addition to potentiating the activity of antibiotics used in combination. The identification of antimalarial drugs as potent inhibitors and adjunct inhibitors of M. abscessus in vivo offers repurposing opportunities that could have an immediate impact in the clinic.
- Published
- 2022
- Full Text
- View/download PDF
12. AC2P20 selectively kills Mycobacterium tuberculosis at acidic pH by depleting free thiols.
- Author
-
Dechow SJ, Coulson GB, Wilson MW, Larsen SD, and Abramovitch RB
- Abstract
Mycobacterium tuberculosis (Mtb) senses and adapts to host immune cues as part of its pathogenesis. One environmental cue sensed by Mtb is the acidic pH of its host niche in the macrophage phagosome. Disrupting the ability of Mtb to sense and adapt to acidic pH has the potential to reduce survival of Mtb in macrophages. Previously, a high throughput screen of a ∼220 000 compound small molecule library was conducted to discover chemical probes that inhibit Mtb growth at acidic pH. The screen discovered chemical probes that kill Mtb at pH 5.7 but are inactive at pH 7.0. In this study, AC2P20 was prioritized for continued study to test the hypothesis that it was targeting Mtb pathways associated with pH-driven adaptation. RNAseq transcriptional profiling studies showed AC2P20 modulates expression of genes associated with redox homeostasis. Gene enrichment analysis revealed that the AC2P20 transcriptional profile had significant overlap with a previously characterized pH-selective inhibitor, AC2P36. Like AC2P36, we show that AC2P20 kills Mtb by selectively depleting free thiols at acidic pH. Mass spectrometry studies show the formation of a disulfide bond between AC2P20 and reduced glutathione, supporting a mechanism where AC2P20 is able to deplete intracellular thiols and dysregulate redox homeostasis. The observation of two independent molecules targeting free thiols to kill Mtb at acidic pH further supports that Mtb has restricted redox homeostasis and sensitivity to thiol-oxidative stress at acidic pH., Competing Interests: R. B. A. is the founder and owner of Tarn Biosciences, Inc., a company that is working to develop new TB drugs., (This journal is © The Royal Society of Chemistry.)
- Published
- 2021
- Full Text
- View/download PDF
13. Genetic Diversity and Potential Paths of Transmission of Mycobacterium bovis in the Amazon: The Discovery of M. bovis Lineage Lb1 Circulating in South America.
- Author
-
Carneiro PA, Zimpel CK, Pasquatti TN, Silva-Pereira TT, Takatani H, Silva CBDG, Abramovitch RB, Sa Guimaraes AM, Davila AMR, Araujo FR, and Kaneene JB
- Abstract
Bovine tuberculosis (bTB) has yet to be eradicated in Brazil. Herds of cattle and buffalo are important sources of revenue to people living in the banks of the Amazon River basin. A better understanding of Mycobacterium bovis (M. bovis) populational structure and transmission dynamics affecting these animals can significantly contribute in efforts to improve their sanitary status. Herein, we sequenced the whole genome of 22 M. bovis isolates (15 from buffalo and 7 from cattle) from 10 municipalities in the region of the Lower Amazon River Basin in Brazil and performed phylogenomic analysis and Single Nucleotide Polymorphism (SNP)-based transmission inference to evaluate population structure and transmission networks. Additionally, we compared these genomes to others obtained in unrelated studies in the Marajó Island ( n = 15) and worldwide ( n = 128) to understand strain diversity in the Amazon and to infer M. bovis lineages. Our results show a higher genomic diversity of M. bovi s genomes obtained in the Lower Amazon River region when compared to the Marajó Island, while no significant difference was observed between M. bovis genomes obtained from cattle and buffalo ( p ≥ 0.05). This high genetic diversity is reflected by the weak phylogenetic clustering of M. bovis from the Lower Amazon River region based on geographic proximity and in the detection of only two putative transmission clusters in the region. One of these clusters is the first description of inter-species transmission between cattle and buffalo in the Amazon, bringing implications to the bTB control program. Surprisingly, two M. bovis lineages were detected in our dataset, namely Lb1 and Lb3, constituting the first description of Lb1 in South America. Most of the strains of this study (13/22) and all 15 strains of the Marajó Island carried no clonal complex marker, suggesting that the recent lineage classification better describe the diversity of M. bovis in the Amazon., Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest., (Copyright © 2021 Carneiro, Zimpel, Pasquatti, Silva-Pereira, Takatani, Silva, Abramovitch, Sa Guimaraes, Davila, Araujo and Kaneene.)
- Published
- 2021
- Full Text
- View/download PDF
14. Macrophage Infection Models for Mycobacterium tuberculosis.
- Author
-
Johnson BK, Thomas SM, Olive AJ, and Abramovitch RB
- Subjects
- Animals, Cells, Cultured, Humans, In Vitro Techniques, Macrophages pathology, Macrophages, Alveolar pathology, Mice, Mycobacterium tuberculosis pathogenicity, Myeloid Cells pathology, Macrophages microbiology, Macrophages, Alveolar microbiology, Molecular Imaging methods, Mycobacterium tuberculosis growth & development, Myeloid Cells microbiology
- Abstract
Mycobacterium tuberculosis colonizes, survives, and grows inside macrophages. In vitro macrophage infection models, using both primary macrophages and cell lines, enable the characterization of the pathogen response to macrophage immune pressure and intracellular environmental cues. We describe methods to propagate and infect primary murine bone marrow-derived macrophages, HoxB8 conditionally immortalized myeloid cells, Max Planck Institute alveolar macrophage-like cells, and J774 and THP-1 macrophage-like cell lines. We also present methods on the characterization of M. tuberculosis intracellular survival and the preparation of infected macrophages for imaging.
- Published
- 2021
- Full Text
- View/download PDF
15. Artemisia annua and Artemisia afra extracts exhibit strong bactericidal activity against Mycobacterium tuberculosis.
- Author
-
Martini MC, Zhang T, Williams JT, Abramovitch RB, Weathers PJ, and Shell SS
- Subjects
- Antitubercular Agents isolation & purification, Artemisia annua, Humans, Microbial Sensitivity Tests methods, Mycobacterium tuberculosis physiology, Plant Extracts isolation & purification, Antitubercular Agents pharmacology, Artemisia, Mycobacterium tuberculosis drug effects, Plant Extracts pharmacology
- Abstract
Ethnopharmacological Relevance: Emergence of drug-resistant and multidrug-resistant Mycobacterium tuberculosis (Mtb) strains is a major barrier to tuberculosis (TB) eradication, as it leads to longer treatment regimens and in many cases treatment failure. Thus, there is an urgent need to explore new TB drugs and combinations, in order to shorten TB treatment and improve outcomes. Here, we evaluated the potential of two Asian and African traditional medicinal plants, Artemisia annua, a natural source of artemisinin (AN), and Artemisia afra, as sources of novel antitubercular agents., Aim of the Study: Our goal was to measure the activity of A. annua and A. afra extracts against Mtb as potential natural and inexpensive therapies for TB treatment, or as sources of compounds that could be further developed into effective treatments., Materials and Methods: The minimum inhibitory concentrations (MICs) of A. annua and A. afra dichloromethane extracts were determined, and concentrations above the MICs were used to evaluate their ability to kill Mtb and Mycobacterium abscessus in vitro., Results: Previous studies showed that A. annua and A. afra inhibit Mtb growth. Here, we show for the first time that Artemisia extracts have a strong bactericidal activity against Mtb. The killing effect of A. annua was much stronger than equivalent concentrations of pure AN, suggesting that A. annua extracts kill Mtb through a combination of AN and additional compounds. A. afra, which produces very little AN, displayed bactericidal activity against Mtb that was substantial but weaker than that of A. annua. In addition, we measured the activity of Artemisia extracts against Mycobacterium abscessus. Interestingly, we observed that while A. annua is not bactericidal, it inhibits growth of M. abscessus, highlighting the potential of this plant in combinatory therapies to treat M. abscessus infections., Conclusion: Our results indicate that Artemisia extracts have an enormous potential for treatment of TB and M. abscessus infections, and that these plants contain bactericidal compounds in addition to AN. Combination of extracts with existing antibiotics may not only improve treatment outcomes but also reduce the emergence of resistance to other drugs., (Copyright © 2020 The Author(s). Published by Elsevier B.V. All rights reserved.)
- Published
- 2020
- Full Text
- View/download PDF
16. Inhibiting DosRST as a new approach to tuberculosis therapy.
- Author
-
Zheng H and Abramovitch RB
- Subjects
- Humans, Microbial Sensitivity Tests, Antitubercular Agents pharmacology, Bacterial Proteins antagonists & inhibitors, DNA-Binding Proteins antagonists & inhibitors, Mycobacterium tuberculosis drug effects, Tuberculosis drug therapy
- Abstract
Progress against tuberculosis (TB) requires faster-acting drugs. Mycobacterium tuberculosis (Mtb) is the leading cause of death by an infectious disease and its treatment is challenging and lengthy. Mtb is remarkably successful, in part, due to its ability to become dormant in response to host immune pressures. The DosRST two-component regulatory system is induced by hypoxia, nitric oxide and carbon monoxide and remodels Mtb physiology to promote nonreplicating persistence (NRP). NRP bacteria are thought to play a role in the long course of TB treatment. Therefore, inhibitors of DosRST-dependent adaptation may function to kill this reservoir of persisters and potentially shorten therapy. This review examines the function of DosRST, newly discovered compounds that inhibit DosRST signaling and considers future development of DosRST inhibitors as adjunct therapies.
- Published
- 2020
- Full Text
- View/download PDF
17. EspM Is a Conserved Transcription Factor That Regulates Gene Expression in Response to the ESX-1 System.
- Author
-
Sanchez KG, Ferrell MJ, Chirakos AE, Nicholson KR, Abramovitch RB, Champion MM, and Champion PA
- Subjects
- Bacterial Proteins metabolism, Gene Expression, Gene Expression Regulation, Bacterial, Mycobacterium marinum pathogenicity, Mycobacterium tuberculosis pathogenicity, Transcription Factors metabolism, Virulence, Bacterial Proteins genetics, Mycobacterium marinum genetics, Mycobacterium smegmatis genetics, Mycobacterium tuberculosis genetics, Transcription Factors genetics
- Abstract
Pathogenic mycobacteria encounter multiple environments during macrophage infection. Temporally, the bacteria are engulfed into the phagosome, lyse the phagosomal membrane, and interact with the cytosol before spreading to another cell. Virulence factors secreted by the mycobacterial ESX-1 (ESAT-6-system-1) secretion system mediate the essential transition from the phagosome to the cytosol. It was recently discovered that the ESX-1 system also regulates mycobacterial gene expression in Mycobacterium marinum (R. E. Bosserman, T. T. Nguyen, K. G. Sanchez, A. E. Chirakos, et al., Proc Natl Acad Sci U S A 114:E10772-E10781, 2017, https://doi.org/10.1073/pnas.1710167114), a nontuberculous mycobacterial pathogen, and in the human-pathogenic species M. tuberculosis (A. M. Abdallah, E. M. Weerdenburg, Q. Guan, R. Ummels, et al., PLoS One 14:e0211003, 2019, https://doi.org/10.1371/journal.pone.0211003). It is not known how the ESX-1 system regulates gene expression. Here, we identify the first transcription factor required for the ESX-1-dependent transcriptional response in pathogenic mycobacteria. We demonstrate that the gene divergently transcribed from the whiB6 gene and adjacent to the ESX-1 locus in mycobacterial pathogens encodes a conserved transcription factor ( MMAR_5438 , Rv3863 , now espM ). We prove that EspM from both M. marinum and M. tuberculosis directly and specifically binds the whiB6-espM intergenic region. We show that EspM is required for ESX-1-dependent repression of whiB6 expression and for the regulation of ESX-1 -associated gene expression. Finally, we demonstrate that EspM functions to fine-tune ESX-1 activity in M. marinum Taking the data together, this report extends the esx-1 locus, defines a conserved regulator of the ESX-1 virulence pathway, and begins to elucidate how the ESX-1 system regulates gene expression. IMPORTANCE Mycobacterial pathogens use the ESX-1 system to transport protein substrates that mediate essential interactions with the host during infection. We previously demonstrated that in addition to transporting proteins, the ESX-1 secretion system regulates gene expression. Here, we identify a conserved transcription factor that regulates gene expression in response to the ESX-1 system. We demonstrate that this transcription factor is functionally conserved in M. marinum , a pathogen of ectothermic animals; M. tuberculosis , the human-pathogenic species that causes tuberculosis; and M. smegmatis , a nonpathogenic mycobacterial species. These findings provide the first mechanistic insight into how the ESX-1 system elicits a transcriptional response, a function of this protein transport system that was previously unknown., (Copyright © 2020 Sanchez et al.)
- Published
- 2020
- Full Text
- View/download PDF
18. Molecular characterization of Mycobacterium bovis infection in cattle and buffalo in Amazon Region, Brazil.
- Author
-
Carneiro PAM, Pasquatti TN, Takatani H, Zumárraga MJ, Marfil MJ, Barnard C, Fitzgerald SD, Abramovitch RB, Araujo FR, and Kaneene JB
- Subjects
- Animals, Bacterial Typing Techniques veterinary, Brazil epidemiology, Cattle, Female, Male, Prevalence, Tuberculosis epidemiology, Tuberculosis, Bovine epidemiology, Buffaloes, Mycobacterium bovis isolation & purification, Tuberculosis veterinary
- Abstract
The aim of this study was to characterize Mycobacterium bovis from cattle and buffalo tissue samples, from two Brazilian states, and to analyse their genetic diversity by spoligotyping. Tissue samples from tuberculosis suspect animals, 57 in Amazonas State (12 cattle and 45 buffaloes) and six from Pará State (5 cattle and one buffalo) from slaughterhouses under State Veterinary Inspection, were isolated in culture medium Stonebrink. The positive cultures were confirmed by PCR and analysed by the spoligotyping technique and the patterns (spoligotypes) were identified and compared at the Mycobacterium bovis Spoligotype Database (http://www.mbovis.org/). There was bacterial growth in 44 (69.8%) of the tissues of the 63 animals, of which PCR for region of differentiation 4 identified 35/44 (79.5%) as Mycobacterium bovis. Six different spoligotypes were identified among the 35 Mycobacterium bovis isolates, of which SB0295, SB1869, SB0121 and SB1800 had already been described in Brazil, and SB0822 and SB1608 had not been described. The most frequent spoligotype in this study (SB0822) had already been described in buffaloes in Colombia, a neighbouring country of Amazonas state. The other identified spoligotypes were also described in other South American countries, such as Argentina and Venezuela, and described in the Brazilian states of Rio Grande do Sul, Santa Catarina, São Paulo, Minas Gerais, Mato Grosso do Sul, Mato Grosso and Goiás, indicating an active movement of Mycobacterium bovis strains within Brazil., (© 2019 The Authors. Veterinary Medicine and Science Published by John Wiley & Sons Ltd.)
- Published
- 2020
- Full Text
- View/download PDF
19. Inhibiting Mycobacterium tuberculosis DosRST Signaling by Targeting Response Regulator DNA Binding and Sensor Kinase Heme.
- Author
-
Zheng H, Williams JT, Aleiwi B, Ellsworth E, and Abramovitch RB
- Subjects
- Anti-Bacterial Agents pharmacology, Bacterial Proteins genetics, DNA-Binding Proteins genetics, Drug Evaluation, Preclinical, Gene Expression Regulation, Bacterial drug effects, Homeostasis, Molecular Structure, Mycobacterium tuberculosis enzymology, Oxidation-Reduction, Protein Kinase Inhibitors pharmacology, Signal Transduction, Structure-Activity Relationship, Anti-Bacterial Agents chemistry, Bacterial Proteins antagonists & inhibitors, DNA chemistry, DNA-Binding Proteins antagonists & inhibitors, Heme metabolism, Mycobacterium tuberculosis genetics, Protein Kinase Inhibitors chemistry
- Abstract
Mycobacterium tuberculosis (Mtb) possesses a two-component regulatory system, DosRST, that enables Mtb to sense host immune cues and establish a state of nonreplicating persistence (NRP). NRP bacteria are tolerant to several antimycobacterial drugs in vitro and are thought to play a role in the long course of tuberculosis therapy. Previously, we reported the discovery of six novel chemical inhibitors of DosRST, named HC101A-106A, from a whole cell, reporter-based phenotypic high throughput screen. Here, we report functional and mechanism of action studies of HC104A and HC106A. RNaseq transcriptional profiling shows that the compounds downregulate genes of the DosRST regulon. Both compounds reduce hypoxia-induced triacylglycerol synthesis by ∼50%. HC106A inhibits Mtb survival during hypoxia-induced NRP; however, HC104A did not inhibit survival during NRP. An electrophoretic mobility assay shows that HC104A inhibits DosR DNA binding in a dose-dependent manner, indicating that HC104A may function by directly targeting DosR. In contrast, UV-visible spectroscopy studies suggest HC106A directly targets the sensor kinase heme, via a mechanism that is distinct from the oxidation and alkylation of heme previously observed with artemisinin (HC101A). Synergistic interactions were observed when DosRST inhibitors were examined in pairwise combinations with the strongest potentiation observed between artemisinin paired with HC102A, HC103A, or HC106A. Our data collectively show that the DosRST pathway can be inhibited by multiple distinct mechanisms.
- Published
- 2020
- Full Text
- View/download PDF
20. Acid Fasting: Modulation of Mycobacterium tuberculosis Metabolism at Acidic pH.
- Author
-
Baker JJ, Dechow SJ, and Abramovitch RB
- Subjects
- Adaptation, Physiological, Carbon metabolism, Hydrogen-Ion Concentration, Mycobacterium tuberculosis growth & development, Oxidation-Reduction, Tuberculosis microbiology, Mycobacterium tuberculosis metabolism
- Abstract
Mycobacterium tuberculosis (Mtb) senses and adapts to acidic host environments during the course of pathogenesis. Mutants defective in acidic pH-dependent adaptations are often attenuated during macrophage or animal infections, supporting that these pathways are essential for pathogenesis and represent important new targets for drug discovery. This review examines a confluence of findings supporting that Mtb has restricted metabolism at acidic pH that results in the slowing of bacterial growth and changes in redox homeostasis. It is proposed that induction of the PhoPR regulon and anaplerotic metabolism, in concert with the restricted use of specific carbon sources, functions to counter reductive stress associated with acidic pH., (Copyright © 2019 Elsevier Ltd. All rights reserved.)
- Published
- 2019
- Full Text
- View/download PDF
21. Identification of New MmpL3 Inhibitors by Untargeted and Targeted Mutant Screens Defines MmpL3 Domains with Differential Resistance.
- Author
-
Williams JT, Haiderer ER, Coulson GB, Conner KN, Ellsworth E, Chen C, Alvarez-Cabrera N, Li W, Jackson M, Dick T, and Abramovitch RB
- Subjects
- Antitubercular Agents chemical synthesis, Bacterial Proteins antagonists & inhibitors, Bacterial Proteins chemistry, Bacterial Proteins metabolism, Benzamides chemical synthesis, Benzothiazoles chemical synthesis, Binding Sites, Biological Transport drug effects, Cord Factors antagonists & inhibitors, Cord Factors biosynthesis, Cord Factors metabolism, Drug Resistance, Bacterial genetics, Galactans metabolism, Gene Expression, High-Throughput Screening Assays, Membrane Transport Proteins chemistry, Membrane Transport Proteins metabolism, Microbial Sensitivity Tests, Models, Molecular, Mutation, Mycobacterium abscessus drug effects, Mycobacterium abscessus genetics, Mycobacterium abscessus growth & development, Mycobacterium abscessus metabolism, Mycobacterium tuberculosis genetics, Mycobacterium tuberculosis growth & development, Mycobacterium tuberculosis metabolism, Mycolic Acids metabolism, Protein Binding, Protein Structure, Secondary, Pyridines chemical synthesis, Recombinant Proteins chemistry, Recombinant Proteins genetics, Recombinant Proteins metabolism, Whole Genome Sequencing, Antitubercular Agents pharmacology, Bacterial Proteins genetics, Benzamides pharmacology, Benzothiazoles pharmacology, Drug Resistance, Bacterial drug effects, Membrane Transport Proteins genetics, Mycobacterium tuberculosis drug effects, Pyridines pharmacology
- Abstract
The Mycobacterium tuberculosis mycolate flippase MmpL3 has been the proposed target for multiple inhibitors with diverse chemical scaffolds. This diversity in chemical scaffolds has made it difficult to predict compounds that inhibit MmpL3 without whole-genome sequencing of isolated resistant mutants. Here, we describe the identification of four new inhibitors that select for resistance mutations in mmpL3. Using these resistant mutants, we conducted a targeted whole-cell phenotypic screen of 163 novel M. tuberculosis growth inhibitors for differential growth inhibition of wild-type M. tuberculosis compared to the growth of a pool of 24 unique mmpL3 mutants. The screen successfully identified six additional putative MmpL3 inhibitors. The compounds were bactericidal both in vitro and against intracellular M. tuberculosis M. tuberculosis cells treated with these compounds were shown to accumulate trehalose monomycolates, have reduced levels of trehalose dimycolate, and displace an MmpL3-specific probe, supporting MmpL3 as the target. The inhibitors were mycobacterium specific, with several also showing activity against the nontuberculous mycobacterial species M. abscessus Cluster analysis of cross-resistance profiles generated by dose-response experiments for each combination of 13 MmpL3 inhibitors against each of the 24 mmpL3 mutants defined two clades of inhibitors and two clades of mmpL3 mutants. Pairwise combination studies of the inhibitors revealed interactions that were specific to the clades identified in the cross-resistance profiling. Additionally, modeling of resistance-conferring substitutions to the MmpL3 crystal structure revealed clade-specific localization of the residues to specific domains of MmpL3, with the clades showing differential resistance. Several compounds exhibited high solubility and stability in microsomes and low cytotoxicity in macrophages, supporting their further development. The combined study of multiple mutants and novel compounds provides new insights into structure-function interactions of MmpL3 and small-molecule inhibitors., (Copyright © 2019 American Society for Microbiology.)
- Published
- 2019
- Full Text
- View/download PDF
22. 2-aminoimidazoles collapse mycobacterial proton motive force and block the electron transport chain.
- Author
-
Jeon AB, Ackart DF, Li W, Jackson M, Melander RJ, Melander C, Abramovitch RB, Chicco AJ, Basaraba RJ, and Obregón-Henao A
- Subjects
- Adenosine Triphosphate metabolism, Antitubercular Agents pharmacology, Biofilms growth & development, Humans, Microbial Sensitivity Tests, Mycobacterium tuberculosis growth & development, Oxygen Consumption drug effects, Tuberculosis microbiology, Biofilms drug effects, Electron Transport drug effects, Imidazoles pharmacology, Mycobacterium tuberculosis drug effects, Proton-Motive Force drug effects, Tuberculosis drug therapy
- Abstract
There is an urgent need to develop new drugs against tuberculosis. In particular, it is critical to target drug tolerant Mycobacterium tuberculosis (M. tuberculosis), responsible, in part, for the lengthy antibiotic regimen required for treatment. We previously postulated that the presence of in vivo biofilm-like communities of M. tuberculosis could contribute to this drug tolerance. Consistent with this hypothesis, certain 2-aminoimidazole (2-AIs) molecules with anti-biofilm activity were shown to revert mycobacterial drug tolerance in an in vitro M. tuberculosis biofilm model. While exploring their mechanism of action, it was serendipitously observed that these 2-AI molecules also potentiated β-lactam antibiotics by affecting mycobacterial protein secretion and lipid export. As these two bacterial processes are energy-dependent, herein it was evaluated if 2-AI compounds affect mycobacterial bioenergetics. At low concentrations, 2B8, the lead 2-AI compound, collapsed both components of the proton motive force, similar to other cationic amphiphiles. Interestingly, however, the minimum inhibitory concentration of 2B8 against M. tuberculosis correlated with a higher drug concentration determined to interfere with the mycobacterial electron transport chain. Collectively, this study elucidates the mechanism of action of 2-AIs against M. tuberculosis, providing a tool to better understand mycobacterial bioenergetics and develop compounds with improved anti-mycobacterial activity.
- Published
- 2019
- Full Text
- View/download PDF
23. Mycobacterium tuberculosis Reporter Strains as Tools for Drug Discovery and Development.
- Author
-
Abramovitch RB
- Subjects
- Animals, Humans, Mycobacterium tuberculosis classification, Mycobacterium tuberculosis drug effects, Tuberculosis microbiology, Antitubercular Agents therapeutic use, Drug Discovery, Genes, Reporter, Host-Pathogen Interactions, Mycobacterium tuberculosis growth & development, Tuberculosis drug therapy
- Abstract
Reporter strains have proven to be powerful tools to study Mycobacterium tuberculosis (Mtb) physiology. Transcriptional and translational reporter strains are engineered by fusing a readout gene, encoding a fluorescent, luminescent or enzymatic protein, downstream of a promoter or in-frame with a gene of interest. When the reporter is expressed, it generates a signal that acts as a synthetic phenotype, enabling the study of physiologies that might have otherwise been hidden. This review will discuss approaches for generating reporter strains in Mtb and how they can be used as tools for high-throughput genetic and small molecule screening and as biomarkers for examining Mtb responses to drug or immune stresses during animal infections. Fluorescent reporter strains have an added benefit in that they can be used for single-cell studies both in vitro and in vivo, thus enabling the study of mechanisms underlying phenotypic heterogeneity. Recent examples of the use of Mtb reporter strains will be presented with a focus on how they can be used as tools for drug discovery and development. © 2018 IUBMB Life, 70(9):818-825, 2018., (© 2018 International Union of Biochemistry and Molecular Biology.)
- Published
- 2018
- Full Text
- View/download PDF
24. HC2091 Kills Mycobacterium tuberculosis by Targeting the MmpL3 Mycolic Acid Transporter.
- Author
-
Zheng H, Williams JT, Coulson GB, Haiderer ER, and Abramovitch RB
- Subjects
- Bacterial Proteins genetics, Bacterial Proteins metabolism, Membrane Transport Proteins genetics, Membrane Transport Proteins metabolism, Microbial Sensitivity Tests, Tuberculosis genetics, Tuberculosis metabolism, Tuberculosis microbiology, Antitubercular Agents pharmacology, Mycobacterium tuberculosis drug effects, Mycobacterium tuberculosis genetics, Mycolic Acids pharmacology
- Abstract
Tuberculosis, caused by the intracellular pathogen Mycobacterium tuberculosis , is a deadly disease that requires a long course of treatment. The emergence of drug-resistant strains has driven efforts to discover new small molecules that can kill the bacterium. Here, we report characterizations of the compound HC2091, which kills M. tuberculosis in a time- and dose-dependent manner in vitro and inhibits M. tuberculosis growth in macrophages. Whole-genome sequencing of spontaneous HC2091-resistant mutants identified single-nucleotide variants in the mmpL3 mycolic acid transporter gene. HC2091-resistant mutants do not exhibit cross-resistance with the well-characterized Mycobacterium membrane protein large 3 (MmpL3) inhibitor SQ109, suggesting a distinct mechanism of interaction with MmpL3. Additionally, HC2091 does not modulate bacterial membrane potential or kill nonreplicating M. tuberculosis , thus acting differently from other known MmpL3 inhibitors. RNA sequencing (RNA-seq) transcriptional profiling and lipid profiling of M. tuberculosis treated with HC2091 or SQ109 show that the two compounds target a similar pathway. HC2091 has a chemical structure dissimilar to those of previously described MmpL3 inhibitors, supporting the notion that HC2091 is a new class of MmpL3 inhibitor., (Copyright © 2018 American Society for Microbiology.)
- Published
- 2018
- Full Text
- View/download PDF
25. Genetic and metabolic regulation of Mycobacterium tuberculosis acid growth arrest.
- Author
-
Baker JJ and Abramovitch RB
- Subjects
- Gene Deletion, Hydrogen-Ion Concentration, Bacterial Proteins genetics, Bacterial Proteins metabolism, Isocitrate Lyase genetics, Isocitrate Lyase metabolism, Mycobacterium tuberculosis genetics, Mycobacterium tuberculosis growth & development, Phosphoenolpyruvate Carboxykinase (ATP) genetics, Phosphoenolpyruvate Carboxykinase (ATP) metabolism
- Abstract
Mycobacterium tuberculosis (Mtb) senses and adapts to acidic environments during the course of infection. Acidic pH-dependent adaptations include the induction of metabolic genes associated with anaplerosis and growth arrest on specific carbon sources. Here we report that deletion of isocitrate lyase or phosphoenolpyruvate carboxykinase results in reduced growth at acidic pH and altered metabolite profiles, supporting that remodeling of anaplerotic metabolism is required for pH-dependent adaptation. Mtb cultured at pH 5.7 in minimal medium containing glycerol as a single carbon source exhibits an acid growth arrest phenotype, where the bacterium is non-replicating but viable and metabolically active. The bacterium assimilates and metabolizes glycerol and maintains ATP pools during acid growth arrest and becomes tolerant to detergent stress and the antibiotics isoniazid and rifampin. A forward genetic screen identified mutants that do not arrest their growth at acidic pH, including four enhanced acid growth (eag) mutants with three distinct mutations in the proline-proline-glutamate (PPE) gene MT3221 (also named ppe51). Overexpression of the MT3221(S211R) variant protein in wild type Mtb results in enhanced acid growth and reduced drug tolerance. These findings support that acid growth arrest is a genetically controlled, adaptive process and not simply a physiological limitation associated with acidic pH.
- Published
- 2018
- Full Text
- View/download PDF
26. WhiB6 regulation of ESX-1 gene expression is controlled by a negative feedback loop in Mycobacterium marinum .
- Author
-
Bosserman RE, Nguyen TT, Sanchez KG, Chirakos AE, Ferrell MJ, Thompson CR, Champion MM, Abramovitch RB, and Champion PA
- Subjects
- Feedback, Physiological, Mycobacterium marinum metabolism, Bacterial Proteins metabolism, Gene Expression Regulation, Bacterial, Mycobacterium marinum genetics, Transcription Factors metabolism, Type VII Secretion Systems genetics
- Abstract
ESX (ESAT-6 system) export systems play diverse roles across mycobacterial species. Interestingly, genetic disruption of ESX systems in different species does not result in an accumulation of protein substrates in the mycobacterial cell. However, the mechanisms underlying this observation are elusive. We hypothesized that the levels of ESX substrates were regulated by a feedback-control mechanism, linking the levels of substrates to the secretory status of ESX systems. To test this hypothesis, we used a combination of genetic, transcriptomic, and proteomic approaches to define export-dependent mechanisms regulating the levels of ESX-1 substrates in Mycobacterium marinum WhiB6 is a transcription factor that regulates expression of genes encoding ESX-1 substrates. We found that, in the absence of the genes encoding conserved membrane components of the ESX-1 system, the expression of the whiB6 gene and genes encoding ESX-1 substrates were reduced. Accordingly, the levels of ESX-1 substrates were decreased, and WhiB6 was not detected in M. marinum strains lacking genes encoding ESX-1 components. We demonstrated that, in the absence of EccCb
1 , a conserved ESX-1 component, substrate gene expression was restored by constitutive, but not native, expression of the whiB6 gene. Finally, we found that the loss of WhiB6 resulted in a virulent M. marinum strain with reduced ESX-1 secretion. Together, our findings demonstrate that the levels of ESX-1 substrates in M. marinum are fine-tuned by negative feedback control, linking the expression of the whiB6 gene to the presence, not the functionality, of the ESX-1 membrane complex., Competing Interests: The authors declare no conflict of interest.- Published
- 2017
- Full Text
- View/download PDF
27. Targeting Mycobacterium tuberculosis Sensitivity to Thiol Stress at Acidic pH Kills the Bacterium and Potentiates Antibiotics.
- Author
-
Coulson GB, Johnson BK, Zheng H, Colvin CJ, Fillinger RJ, Haiderer ER, Hammer ND, and Abramovitch RB
- Subjects
- Anti-Bacterial Agents chemistry, Bacterial Proteins genetics, Bacterial Proteins metabolism, Glutathione chemistry, Hydrogen-Ion Concentration, Mycobacterium tuberculosis growth & development, Oxidative Stress drug effects, Pyrimidines chemistry, Reactive Oxygen Species metabolism, Sigma Factor genetics, Sigma Factor metabolism, Structure-Activity Relationship, Sulfhydryl Compounds chemistry, Sulfones chemistry, Anti-Bacterial Agents pharmacology, Mycobacterium tuberculosis drug effects, Pyrimidines pharmacology, Sulfhydryl Compounds metabolism, Sulfones pharmacology
- Abstract
Mycobacterium tuberculosis (Mtb) must sense and adapt to immune pressures such as acidic pH during pathogenesis. The goal of this study was to isolate compounds that inhibit acidic pH resistance, thus defining virulence pathways that are vulnerable to chemotherapy. Here, we report that the compound AC2P36 selectively kills Mtb at acidic pH and potentiates the bactericidal activity of isoniazid, clofazimine, and diamide. We show that AC2P36 activity is associated with thiol stress and causes an enhanced accumulation of intracellular reactive oxygen species at acidic pH. Mechanism of action studies demonstrate that AC2P36 directly depletes Mtb thiol pools, with enhanced depletion of free thiols at acidic pH. These findings support that Mtb is especially vulnerable to thiol stress at acidic pH and that chemical depletion of thiol pools is a promising target to promote Mtb killing and potentiation of antimicrobials., (Copyright © 2017 Elsevier Ltd. All rights reserved.)
- Published
- 2017
- Full Text
- View/download PDF
28. 2-aminoimidazoles potentiate ß-lactam antimicrobial activity against Mycobacterium tuberculosis by reducing ß-lactamase secretion and increasing cell envelope permeability.
- Author
-
Jeon AB, Obregón-Henao A, Ackart DF, Podell BK, Belardinelli JM, Jackson M, Nguyen TV, Blackledge MS, Melander RJ, Melander C, Johnson BK, Abramovitch RB, and Basaraba RJ
- Subjects
- Carbenicillin pharmacology, Coloring Agents chemistry, Lipids analysis, Microbial Sensitivity Tests, Mycobacterium tuberculosis drug effects, Mycobacterium tuberculosis growth & development, Nucleic Acids metabolism, Penicillin V pharmacology, Sodium Dodecyl Sulfate pharmacology, Staining and Labeling, Transcription, Genetic drug effects, Vancomycin pharmacology, Anti-Infective Agents pharmacology, Cell Membrane Permeability drug effects, Imidazoles pharmacology, Mycobacterium tuberculosis cytology, Mycobacterium tuberculosis enzymology, beta-Lactamases metabolism, beta-Lactams pharmacology
- Abstract
There is an urgent need to develop new drug treatment strategies to control the global spread of drug-sensitive and multidrug-resistant Mycobacterium tuberculosis (M. tuberculosis). The ß-lactam class of antibiotics is among the safest and most widely prescribed antibiotics, but they are not effective against M. tuberculosis due to intrinsic resistance. This study shows that 2-aminoimidazole (2-AI)-based small molecules potentiate ß-lactam antibiotics against M. tuberculosis. Active 2-AI compounds significantly reduced the minimal inhibitory and bactericidal concentrations of ß-lactams by increasing M. tuberculosis cell envelope permeability and decreasing protein secretion including ß-lactamase. Metabolic labeling and transcriptional profiling experiments revealed that 2-AI compounds impair mycolic acid biosynthesis, export and linkage to the mycobacterial envelope, counteracting an important defense mechanism reducing permeability to external agents. Additionally, other important constituents of the M. tuberculosis outer membrane including sulfolipid-1 and polyacyltrehalose were also less abundant in 2-AI treated bacilli. As a consequence of 2-AI treatment, M. tuberculosis displayed increased sensitivity to SDS, increased permeability to nucleic acid staining dyes, and rapid binding of cell wall targeting antibiotics. Transcriptional profiling analysis further confirmed that 2-AI induces transcriptional regulators associated with cell envelope stress. 2-AI based small molecules potentiate the antimicrobial activity of ß-lactams by a mechanism that is distinct from specific inhibitors of ß-lactamase activity and therefore may have value as an adjunctive anti-TB treatment.
- Published
- 2017
- Full Text
- View/download PDF
29. A bioluminescent Pseudomonas aeruginosa wound model reveals increased mortality of type 1 diabetic mice to biofilm infection.
- Author
-
Agostinho Hunt AM, Gibson JA, Larrivee CL, O'Reilly S, Navitskaya S, Needle DB, Abramovitch RB, Busik JV, and Waters CM
- Subjects
- Animals, Male, Mice, Microorganisms, Genetically-Modified, Pseudomonas Infections mortality, Pseudomonas Infections physiopathology, Pseudomonas aeruginosa genetics, Wound Infection mortality, Wound Infection physiopathology, Biofilms, Diabetes Mellitus, Experimental physiopathology, Diabetes Mellitus, Type 1 physiopathology, Pseudomonas Infections pathology, Wound Healing, Wound Infection pathology
- Abstract
Objective: To examine how bacterial biofilms, as contributing factors in the delayed closure of chronic wounds in patients with diabetes, affect the healing process., Method: We used daily microscopic imaging and the IVIS Spectrum in vivo imaging system to monitor biofilm infections of bioluminescent Pseudomonas aeruginosa and evaluate healing in non-diabetic and streptozotocin-induced diabetic mice., Results: Our studies determined that diabetes alone did not affect the rate of healing of full-depth murine back wounds compared with non-diabetic mice. The application of mature biofilms to the wounds significantly decreased the rate of healing compared with non-infected wounds for both non-diabetic as well as diabetic mice. Diabetic mice were also more severely affected by biofilms displaying elevated pus production, higher mortality rates and statistically significant increase in wound depth, granulation/fibrosis and biofilm presence. Introduction of a mutant Pseudomonas aeruginosa capable of producing high concentrations of cyclic di-GMP did not result in increased persistence in either diabetic or non-diabetic animals compared with the wild type strain., Conclusion: Understanding the interplay between diabetes and biofilms may lead to novel treatments and better clinical management of chronic wounds.
- Published
- 2017
- Full Text
- View/download PDF
30. Small Molecules That Sabotage Bacterial Virulence.
- Author
-
Johnson BK and Abramovitch RB
- Subjects
- Artemisinins pharmacology, Bacteria metabolism, Bacterial Adhesion drug effects, Bacterial Proteins antagonists & inhibitors, Ethoxzolamide pharmacology, Fimbriae, Bacterial drug effects, Histidine Kinase physiology, Sulfonamides pharmacology, Anti-Bacterial Agents pharmacology, Bacteria pathogenicity, Virulence drug effects
- Abstract
The continued rise of antibiotic-resistant bacterial infections has motivated alternative strategies for target discovery and treatment of infections. Antivirulence therapies function through inhibition of in vivo required virulence factors to disarm the pathogen instead of directly targeting viability or growth. This approach to treating bacteria-mediated diseases may have advantages over traditional antibiotics because it targets factors specific for pathogenesis, potentially reducing selection for resistance and limiting collateral damage to the resident microbiota. This review examines vulnerable molecular mechanisms used by bacteria to cause disease and the antivirulence compounds that sabotage these virulence pathways. By expanding the study of antimicrobial targets beyond those that are essential for growth, antivirulence strategies offer new and innovative opportunities to combat infectious diseases., (Copyright © 2017 Elsevier Ltd. All rights reserved.)
- Published
- 2017
- Full Text
- View/download PDF
31. Inhibitors of Mycobacterium tuberculosis DosRST signaling and persistence.
- Author
-
Zheng H, Colvin CJ, Johnson BK, Kirchhoff PD, Wilson M, Jorgensen-Muga K, Larsen SD, and Abramovitch RB
- Subjects
- Artemisinins chemistry, Dose-Response Relationship, Drug, Drug Discovery, Histidine Kinase metabolism, Molecular Structure, Protein Kinase Inhibitors chemistry, Structure-Activity Relationship, Artemisinins pharmacology, Histidine Kinase antagonists & inhibitors, Mycobacterium tuberculosis enzymology, Protein Kinase Inhibitors pharmacology, Signal Transduction drug effects
- Abstract
The Mycobacterium tuberculosis (Mtb) DosRST two-component regulatory system promotes the survival of Mtb during non-replicating persistence (NRP). NRP bacteria help drive the long course of tuberculosis therapy; therefore, chemical inhibition of DosRST may inhibit the ability of Mtb to establish persistence and thus shorten treatment. Using a DosRST-dependent fluorescent Mtb reporter strain, a whole-cell phenotypic high-throughput screen of a ∼540,000 compound small-molecule library was conducted. The screen discovered novel inhibitors of the DosRST regulon, including three compounds that were subject to follow-up studies: artemisinin, HC102A and HC103A. Under hypoxia, all three compounds inhibit Mtb-persistence-associated physiological processes, including triacylglycerol synthesis, survival and antibiotic tolerance. Artemisinin functions by disabling the heme-based DosS and DosT sensor kinases by oxidizing ferrous heme and generating heme-artemisinin adducts. In contrast, HC103A inhibits DosS and DosT autophosphorylation activity without targeting the sensor kinase heme.
- Published
- 2017
- Full Text
- View/download PDF
32. A Nonsense Mutation in Mycobacterium marinum That Is Suppressible by a Novel Mechanism.
- Author
-
Williams EA, Mba Medie F, Bosserman RE, Johnson BK, Reyna C, Ferrell MJ, Champion MM, Abramovitch RB, and Champion PA
- Subjects
- Amino Acid Sequence, Bacterial Proteins chemistry, Bacterial Proteins metabolism, Base Sequence, Mycobacterium Infections, Nontuberculous microbiology, Mycobacterium marinum metabolism, Mycobacterium marinum pathogenicity, Phenotype, Protein Transport, Virulence, Bacterial Proteins genetics, Codon, Nonsense, Gene Expression Regulation, Bacterial, Mycobacterium marinum genetics
- Abstract
Mycobacterial pathogens use the ESAT-6 system 1 (Esx-1) exporter to promote virulence. Previously, we used gene disruption and complementation to conclude that the MMAR_0039 gene in Mycobacterium marinum is required to promote Esx-1 export. Here we applied molecular genetics, proteomics, and whole-genome sequencing to demonstrate that the MMAR_0039 gene is not required for Esx-1 secretion or virulence. These findings suggest that we initially observed an indirect mechanism of genetic complementation. We identified a spontaneous nonsense mutation in a known Esx-1-associated gene which causes a loss of Esx-1 activity. We show that the Esx-1 function was restored by nonsense suppression. Moreover, we identified a polar mutation in the ppsC gene which reduced cellular impermeability but did not impact cytotoxicity in macrophages. Our studies reveal insight into Esx-1 export, nonsense suppression, and cell envelope lipid biogenesis., (Copyright © 2017 American Society for Microbiology.)
- Published
- 2017
- Full Text
- View/download PDF
33. Polysorbates prevent biofilm formation and pathogenesis of Escherichia coli O104:H4.
- Author
-
Sloup RE, Cieza RJ, Needle DB, Abramovitch RB, Torres AG, and Waters CM
- Abstract
Escherichia coli biotype O104:H4 recently caused the deadliest E. coli outbreak ever reported. Based on prior results, it was hypothesized that compounds inhibiting biofilm formation by O104:H4 would reduce its pathogenesis. The nonionic surfactants polysorbate 80 (PS80) and polysorbate 20 (PS20) were found to reduce biofilms by ≥ 90% at submicromolar concentrations and elicited nearly complete dispersal of preformed biofilms. PS80 did not significantly impact in vivo colonization in a mouse infection model; however, mice treated with PS80 exhibited almost no intestinal inflammation or tissue damage while untreated mice exhibited robust pathology. As PS20 and PS80 are classified as 'Generally Recognized as Safe' (GRAS) compounds by the Food and Drug Administration (FDA), these compounds have clinical potential to treat future O104:H4 outbreaks.
- Published
- 2016
- Full Text
- View/download PDF
34. Immune activation of the host cell induces drug tolerance in Mycobacterium tuberculosis both in vitro and in vivo.
- Author
-
Liu Y, Tan S, Huang L, Abramovitch RB, Rohde KH, Zimmerman MD, Chen C, Dartois V, VanderVen BC, and Russell DG
- Subjects
- Animals, Cell Line, Lung immunology, Lung microbiology, Mice, Myeloid Cells immunology, Myeloid Cells microbiology, Tuberculosis, Pulmonary drug therapy, Tuberculosis, Pulmonary immunology, Drug Resistance, Bacterial drug effects, Drug Resistance, Bacterial immunology, Gene Expression Regulation, Bacterial drug effects, Gene Expression Regulation, Bacterial immunology, Isoniazid pharmacology, Mycobacterium tuberculosis immunology, Rifampin pharmacology, Transcription, Genetic drug effects, Transcription, Genetic immunology
- Abstract
Successful chemotherapy against Mycobacterium tuberculosis (Mtb) must eradicate the bacterium within the context of its host cell. However, our understanding of the impact of this environment on antimycobacterial drug action remains incomplete. Intriguingly, we find that Mtb in myeloid cells isolated from the lungs of experimentally infected mice exhibit tolerance to both isoniazid and rifampin to a degree proportional to the activation status of the host cells. These data are confirmed by in vitro infections of resting versus activated macrophages where cytokine-mediated activation renders Mtb tolerant to four frontline drugs. Transcriptional analysis of intracellular Mtb exposed to drugs identified a set of genes common to all four drugs. The data imply a causal linkage between a loss of fitness caused by drug action and Mtb's sensitivity to host-derived stresses. Interestingly, the environmental context exerts a more dominant impact on Mtb gene expression than the pressure on the drugs' primary targets. Mtb's stress responses to drugs resemble those mobilized after cytokine activation of the host cell. Although host-derived stresses are antimicrobial in nature, they negatively affect drug efficacy. Together, our findings demonstrate that the macrophage environment dominates Mtb's response to drug pressure and suggest novel routes for future drug discovery programs., (© 2016 Liu et al.)
- Published
- 2016
- Full Text
- View/download PDF
35. SPARTA: Simple Program for Automated reference-based bacterial RNA-seq Transcriptome Analysis.
- Author
-
Johnson BK, Scholz MB, Teal TK, and Abramovitch RB
- Subjects
- Automation, Reference Standards, Computational Biology methods, Gene Expression Profiling methods, High-Throughput Nucleotide Sequencing methods, RNA, Bacterial genetics, Sequence Analysis, RNA methods, Software, Transcriptome genetics
- Abstract
Background: Many tools exist in the analysis of bacterial RNA sequencing (RNA-seq) transcriptional profiling experiments to identify differentially expressed genes between experimental conditions. Generally, the workflow includes quality control of reads, mapping to a reference, counting transcript abundance, and statistical tests for differentially expressed genes. In spite of the numerous tools developed for each component of an RNA-seq analysis workflow, easy-to-use bacterially oriented workflow applications to combine multiple tools and automate the process are lacking. With many tools to choose from for each step, the task of identifying a specific tool, adapting the input/output options to the specific use-case, and integrating the tools into a coherent analysis pipeline is not a trivial endeavor, particularly for microbiologists with limited bioinformatics experience., Results: To make bacterial RNA-seq data analysis more accessible, we developed a Simple Program for Automated reference-based bacterial RNA-seq Transcriptome Analysis (SPARTA). SPARTA is a reference-based bacterial RNA-seq analysis workflow application for single-end Illumina reads. SPARTA is turnkey software that simplifies the process of analyzing RNA-seq data sets, making bacterial RNA-seq analysis a routine process that can be undertaken on a personal computer or in the classroom. The easy-to-install, complete workflow processes whole transcriptome shotgun sequencing data files by trimming reads and removing adapters, mapping reads to a reference, counting gene features, calculating differential gene expression, and, importantly, checking for potential batch effects within the data set. SPARTA outputs quality analysis reports, gene feature counts and differential gene expression tables and scatterplots., Conclusions: SPARTA provides an easy-to-use bacterial RNA-seq transcriptional profiling workflow to identify differentially expressed genes between experimental conditions. This software will enable microbiologists with limited bioinformatics experience to analyze their data and integrate next generation sequencing (NGS) technologies into the classroom. The SPARTA software and tutorial are available at sparta.readthedocs.org.
- Published
- 2016
- Full Text
- View/download PDF
36. The Carbonic Anhydrase Inhibitor Ethoxzolamide Inhibits the Mycobacterium tuberculosis PhoPR Regulon and Esx-1 Secretion and Attenuates Virulence.
- Author
-
Johnson BK, Colvin CJ, Needle DB, Mba Medie F, Champion PA, and Abramovitch RB
- Subjects
- Animals, Antigens, Bacterial genetics, Bacterial Proteins genetics, Carbonic Anhydrases genetics, Carbonic Anhydrases metabolism, Cells, Cultured, Down-Regulation drug effects, Down-Regulation genetics, Gene Expression Regulation, Bacterial drug effects, Gene Expression Regulation, Bacterial genetics, Macrophages drug effects, Macrophages metabolism, Macrophages microbiology, Mice, Mice, Inbred C57BL, Mutation drug effects, Mutation genetics, Mycobacterium tuberculosis metabolism, Tuberculosis drug therapy, Tuberculosis genetics, Tuberculosis metabolism, Tuberculosis microbiology, Virulence genetics, Antigens, Bacterial metabolism, Bacterial Proteins metabolism, Carbonic Anhydrase Inhibitors pharmacology, Ethoxzolamide pharmacology, Mycobacterium tuberculosis drug effects, Mycobacterium tuberculosis genetics, Regulon drug effects, Virulence drug effects
- Abstract
Mycobacterium tuberculosis must sense and adapt to host environmental cues to establish and maintain an infection. The two-component regulatory system PhoPR plays a central role in sensing and responding to acidic pH within the macrophage and is required for M. tuberculosis intracellular replication and growth in vivo. Therefore, the isolation of compounds that inhibit PhoPR-dependent adaptation may identify new antivirulence therapies to treat tuberculosis. Here, we report that the carbonic anhydrase inhibitor ethoxzolamide inhibits the PhoPR regulon and reduces pathogen virulence. We show that treatment of M. tuberculosis with ethoxzolamide recapitulates phoPR mutant phenotypes, including downregulation of the core PhoPR regulon, altered accumulation of virulence-associated lipids, and inhibition of Esx-1 protein secretion. Quantitative single-cell imaging of a PhoPR-dependent fluorescent reporter strain demonstrates that ethoxzolamide inhibits PhoPR-regulated genes in infected macrophages and mouse lungs. Moreover, ethoxzolamide reduces M. tuberculosis growth in both macrophages and infected mice. Ethoxzolamide inhibits M. tuberculosis carbonic anhydrase activity, supporting a previously unrecognized link between carbonic anhydrase activity and PhoPR signaling. We propose that ethoxzolamide may be pursued as a new class of antivirulence therapy that functions by modulating expression of the PhoPR regulon and Esx-1-dependent virulence., (Copyright © 2015, American Society for Microbiology. All Rights Reserved.)
- Published
- 2015
- Full Text
- View/download PDF
37. Novel inhibitors of cholesterol degradation in Mycobacterium tuberculosis reveal how the bacterium's metabolism is constrained by the intracellular environment.
- Author
-
VanderVen BC, Fahey RJ, Lee W, Liu Y, Abramovitch RB, Memmott C, Crowe AM, Eltis LD, Perola E, Deininger DD, Wang T, Locher CP, and Russell DG
- Subjects
- Adenylyl Cyclases genetics, Animals, Bacterial Proteins metabolism, Cell Line, Cyclic AMP metabolism, Hydroxysteroid Dehydrogenases antagonists & inhibitors, Intracellular Space, Macrophages immunology, Mice, Microbial Sensitivity Tests, Mixed Function Oxygenases antagonists & inhibitors, Mycobacterium tuberculosis growth & development, Oxo-Acid-Lyases antagonists & inhibitors, Small Molecule Libraries pharmacology, Tuberculosis, Pulmonary drug therapy, Antitubercular Agents pharmacology, Cholesterol metabolism, Lipid Metabolism drug effects, Macrophages microbiology, Mycobacterium tuberculosis metabolism
- Abstract
Mycobacterium tuberculosis (Mtb) relies on a specialized set of metabolic pathways to support growth in macrophages. By conducting an extensive, unbiased chemical screen to identify small molecules that inhibit Mtb metabolism within macrophages, we identified a significant number of novel compounds that limit Mtb growth in macrophages and in medium containing cholesterol as the principle carbon source. Based on this observation, we developed a chemical-rescue strategy to identify compounds that target metabolic enzymes involved in cholesterol metabolism. This approach identified two compounds that inhibit the HsaAB enzyme complex, which is required for complete degradation of the cholesterol A/B rings. The strategy also identified an inhibitor of PrpC, the 2-methylcitrate synthase, which is required for assimilation of cholesterol-derived propionyl-CoA into the TCA cycle. These chemical probes represent new classes of inhibitors with novel modes of action, and target metabolic pathways required to support growth of Mtb in its host cell. The screen also revealed a structurally-diverse set of compounds that target additional stage(s) of cholesterol utilization. Mutants resistant to this class of compounds are defective in the bacterial adenylate cyclase Rv1625/Cya. These data implicate cyclic-AMP (cAMP) in regulating cholesterol utilization in Mtb, and are consistent with published reports indicating that propionate metabolism is regulated by cAMP levels. Intriguingly, reversal of the cholesterol-dependent growth inhibition caused by this subset of compounds could be achieved by supplementing the media with acetate, but not with glucose, indicating that Mtb is subject to a unique form of metabolic constraint induced by the presence of cholesterol.
- Published
- 2015
- Full Text
- View/download PDF
38. Macrophage infection models for Mycobacterium tuberculosis.
- Author
-
Johnson BK and Abramovitch RB
- Subjects
- Animals, Cell Separation methods, In Vitro Techniques, Interferon-gamma pharmacology, Lipopolysaccharides immunology, Macrophage Activation drug effects, Macrophage Activation immunology, Macrophages drug effects, Macrophages immunology, Mice, Primary Cell Culture methods, Macrophages microbiology, Mycobacterium tuberculosis physiology
- Abstract
Mycobacterium tuberculosis colonizes, survives, and grows inside macrophages. In vitro macrophage infection models, using both primary macrophages and cell lines, enable the characterization of the pathogen response to macrophage immune pressure and intracellular environmental cues. We describe methods to propagate and infect primary murine bone marrow-derived macrophages and J774 and THP-1 macrophage-like cell lines. We also present methods on the characterization of M. tuberculosis intracellular survival and the preparation of infected macrophages for imaging.
- Published
- 2015
- Full Text
- View/download PDF
39. Slow growth of Mycobacterium tuberculosis at acidic pH is regulated by phoPR and host-associated carbon sources.
- Author
-
Baker JJ, Johnson BK, and Abramovitch RB
- Subjects
- Acids metabolism, Bacterial Proteins genetics, Citric Acid Cycle, Gene Expression Regulation, Bacterial, Glycolysis, Humans, Hydrogen-Ion Concentration, Mycobacterium tuberculosis genetics, Tuberculosis metabolism, Bacterial Proteins metabolism, Carbon metabolism, Mycobacterium tuberculosis growth & development, Mycobacterium tuberculosis metabolism, Tuberculosis microbiology
- Abstract
During pathogenesis, Mycobacterium tuberculosis (Mtb) colonizes environments, such as the macrophage or necrotic granuloma, that are acidic and rich in cholesterol and fatty acids. The goal of this study was to examine how acidic pH and available carbon sources interact to regulate Mtb physiology. Here we report that Mtb growth at acidic pH requires host-associated carbon sources that function at the intersection of glycolysis and the TCA cycle, such as pyruvate, acetate, oxaloacetate and cholesterol. In contrast, in other tested carbon sources, Mtb fully arrests its growth at acidic pH and establishes a state of non-replicating persistence. Growth-arrested Mtb is resuscitated by the addition of pyruvate suggesting that growth arrest is due to a pH-dependent checkpoint on metabolism. Additionally, we demonstrate that the phoPR two-component regulatory system is required to slow Mtb growth at acidic pH and functions to maintain redox homeostasis. Transcriptional profiling and functional metabolic studies demonstrate that signals from acidic pH and carbon source are integrated to remodel pathways associated with anaplerotic central metabolism, lipid anabolism and the regeneration of oxidized cofactors. Because phoPR is required for Mtb virulence in animals, we suggest that pH-driven adaptation may be critical to Mtb pathogenesis., (© 2014 John Wiley & Sons Ltd.)
- Published
- 2014
- Full Text
- View/download PDF
40. Mycobacterium tuberculosis responds to chloride and pH as synergistic cues to the immune status of its host cell.
- Author
-
Tan S, Sukumar N, Abramovitch RB, Parish T, and Russell DG
- Subjects
- Animals, Bacterial Proteins metabolism, Bone Marrow Cells, Cells, Cultured, Cellular Microenvironment physiology, Gene Expression Regulation, Bacterial, Hydrogen-Ion Concentration, Interferon-gamma genetics, Macrophages microbiology, Mice, Mice, Inbred C57BL, Mycobacterium tuberculosis drug effects, Mycobacterium tuberculosis immunology, Mycobacterium tuberculosis physiology, Phagosomes microbiology, Promoter Regions, Genetic, Chlorides pharmacology, Macrophages immunology, Mycobacterium tuberculosis pathogenicity, Phagosomes metabolism, Tuberculosis microbiology
- Abstract
The ability of Mycobacterium tuberculosis (Mtb) to thrive in its phagosomal niche is critical for its establishment of a chronic infection. This requires that Mtb senses and responds to intraphagosomal signals such as pH. We hypothesized that Mtb would respond to additional intraphagosomal factors that correlate with maturation. Here, we demonstrate that [Cl⁻] and pH correlate inversely with phagosome maturation, and identify Cl⁻ as a novel environmental cue for Mtb. Mtb responds to Cl⁻ and pH synergistically, in part through the activity of the two-component regulator phoPR. Following identification of promoters responsive to Cl⁻ and pH, we generated a reporter Mtb strain that detected immune-mediated changes in the phagosomal environment during infection in a mouse model. Our study establishes Cl⁻ and pH as linked environmental cues for Mtb, and illustrates the utility of reporter bacterial strains for the study of Mtb-host interactions in vivo.
- Published
- 2013
- Full Text
- View/download PDF
41. aprABC: a Mycobacterium tuberculosis complex-specific locus that modulates pH-driven adaptation to the macrophage phagosome.
- Author
-
Abramovitch RB, Rohde KH, Hsu FF, and Russell DG
- Subjects
- Artificial Gene Fusion, Fluorescence, Gene Deletion, Gene Expression Regulation, Bacterial, Genes, Reporter, Hydrogen-Ion Concentration, Mycobacterium tuberculosis growth & development, Signal Transduction, Bacterial Proteins genetics, Bacterial Proteins metabolism, Macrophages microbiology, Mycobacterium tuberculosis physiology, Phagosomes microbiology, Stress, Physiological
- Abstract
Following phagocytosis by macrophages, Mycobacterium tuberculosis (Mtb) senses the intracellular environment and remodels its gene expression for growth in the phagosome. We have identified an acid and phagosome regulated (aprABC) locus that is unique to the Mtb complex and whose gene expression is induced during growth in acidic environments in vitro and in macrophages. Using the aprA promoter, we generated a strain that exhibits high levels of inducible fluorescence in response to growth in acidic medium in vitro and in macrophages. aprABC expression is dependent on the two-component regulator phoPR, linking phoPR signalling to pH sensing. Deletion of the aprABC locus causes defects in gene expression that impact aggregation, intracellular growth, and the relative levels of storage and cell wall lipids. We propose a model where phoPR senses the acidic pH of the phagosome and induces aprABC expression to fine-tune processes unique for intracellular adaptation of Mtb complex bacteria., (© 2011 Blackwell Publishing Ltd.)
- Published
- 2011
- Full Text
- View/download PDF
42. Mycobacterium tuberculosis wears what it eats.
- Author
-
Russell DG, VanderVen BC, Lee W, Abramovitch RB, Kim MJ, Homolka S, Niemann S, and Rohde KH
- Subjects
- Animals, Host-Pathogen Interactions, Humans, Lipid Metabolism, Mycobacterium tuberculosis genetics, Stress, Physiological, Tuberculosis metabolism, Mycobacterium tuberculosis physiology, Tuberculosis microbiology
- Abstract
Mycobacterium tuberculosis remains one of the most pernicious of human pathogens. Current vaccines are ineffective, and drugs, although efficacious, require prolonged treatment with constant medical oversight. Overcoming these problems requires a greater appreciation of M. tuberculosis in the context of its host. Upon infection of either macrophages in culture or animal models, the bacterium realigns its metabolism in response to the new environments it encounters. Understanding these environments, and the stresses that they place on M. tuberculosis, should provide insights invaluable for the development of new chemo- and immunotherapeutic strategies., (Copyright 2010 Elsevier Inc. All rights reserved.)
- Published
- 2010
- Full Text
- View/download PDF
43. Mycobacterium tuberculosis invasion of macrophages: linking bacterial gene expression to environmental cues.
- Author
-
Rohde KH, Abramovitch RB, and Russell DG
- Subjects
- Animals, Bone Marrow immunology, Cells, Cultured, Gene Expression Profiling, Genes, Bacterial genetics, Hydrogen-Ion Concentration, Mice, Mycobacterium bovis genetics, Oligonucleotide Array Sequence Analysis, Phagosomes chemistry, Phagosomes microbiology, RNA genetics, RNA, Bacterial genetics, Species Specificity, Gene Expression Regulation, Bacterial, Macrophages metabolism, Macrophages microbiology, Mycobacterium tuberculosis genetics, Tuberculosis microbiology
- Abstract
A central feature of Mycobacterium tuberculosis (Mtb) pathogenesis is the ability of Mtb to survive within macrophages (MØ). Despite its critical importance, our appreciation of the interplay between these two cells remains superficial. We employed microarrays to conduct a stepwise dissection of Mtb-MØ interaction during the invasion of resting bone marrow MØ. Contrary to many bacterial pathogens, engagement by MØ receptors without internalization did not alter Mtb gene expression. Subsequently, a high-resolution profile of Mtb invasion-linked gene expression was generated by assaying the Mtb transcriptome at 20 min intervals up to 2 hr postinfection. Transcriptional responses were detected within minutes of phagocytosis, including gene subsets with distinct temporal profiles. Pharmacological manipulation of phagosomal pH and in vitro acid stress studies revealed that vacuole acidification is an important trigger for differential gene expression. Finally, there are marked species-specific differences in the response of Mtb and M. bovis BCG to intraphagosomal cues.
- Published
- 2007
- Full Text
- View/download PDF
44. The N-terminal region of Pseudomonas type III effector AvrPtoB elicits Pto-dependent immunity and has two distinct virulence determinants.
- Author
-
Xiao F, He P, Abramovitch RB, Dawson JE, Nicholson LK, Sheen J, and Martin GB
- Subjects
- Amino Acid Sequence, Apoptosis genetics, Arabidopsis genetics, Arabidopsis metabolism, Arabidopsis microbiology, Bacterial Proteins chemistry, Bacterial Proteins genetics, Blotting, Western, Immunity, Innate genetics, Solanum lycopersicum genetics, Solanum lycopersicum metabolism, Solanum lycopersicum microbiology, Molecular Sequence Data, Mutagenesis, Plant Diseases genetics, Plant Proteins genetics, Polymerase Chain Reaction, Protein Binding, Protein Serine-Threonine Kinases genetics, Protein Structure, Tertiary, Pseudomonas syringae genetics, Pseudomonas syringae pathogenicity, Sequence Homology, Amino Acid, Structure-Activity Relationship, Two-Hybrid System Techniques, Virulence genetics, Bacterial Proteins metabolism, Plant Diseases microbiology, Plant Proteins metabolism, Protein Serine-Threonine Kinases metabolism, Pseudomonas syringae metabolism
- Abstract
Resistance to bacterial speck disease in tomato is activated by the physical interaction of the host Pto kinase with either of the sequence-dissimilar type III effector proteins AvrPto or AvrPtoB (HopAB2) from Pseudomonas syringae pv. tomato. Pto-mediated immunity requires Prf, a protein with a nucleotide-binding site and leucine-rich repeats. The N-terminal 307 amino acids of AvrPtoB were previously reported to interact with the Pto kinase, and we show here that this region (AvrPtoB(1-307)) is sufficient for eliciting Pto/Prf-dependent immunity against P. s. pv. tomato. AvrPtoB(1-307) was also found to be sufficient for a virulence activity that enhances ethylene production and increases growth of P. s. pv. tomato and severity of speck disease on susceptible tomato lines lacking either Pto or Prf. Moreover, we found that residues 308-387 of AvrPtoB are required for the previously reported ability of AvrPtoB to suppress pathogen-associated molecular patterns-induced basal defenses in Arabidopsis. Thus, the N-terminal region of AvrPtoB has two structurally distinct domains involved in different virulence-promoting mechanisms. Random and targeted mutagenesis identified five tightly clustered residues in AvrPtoB(1-307) that are required for interaction with Pto and for elicitation of immunity to P. s. pv. tomato. Mutation of one of the five clustered residues abolished the ethylene-associated virulence activity of AvrPtoB(1-307). However, individual mutations of the other four residues, despite abolishing interaction with Pto and avirulence activity, had no effect on AvrPtoB(1-307) virulence activity. None of these mutations affected the basal defense-suppressing activity of AvrPtoB(1-387). Based on sequence alignments, estimates of helical propensity, and the previously reported structure of AvrPto, we hypothesize that the Pto-interacting domains of AvrPto and AvrPtoB(1-307) have structural similarity. Together, these data support a model in which AvrPtoB(1-307) promotes ethylene-associated virulence by interaction not with Pto but with another unknown host protein.
- Published
- 2007
- Full Text
- View/download PDF
45. A bacterial E3 ubiquitin ligase targets a host protein kinase to disrupt plant immunity.
- Author
-
Rosebrock TR, Zeng L, Brady JJ, Abramovitch RB, Xiao F, and Martin GB
- Subjects
- Solanum lycopersicum classification, Solanum lycopersicum enzymology, Phenotype, Plant Diseases microbiology, Proteasome Endopeptidase Complex metabolism, Protein Binding, Pseudomonas syringae immunology, Ubiquitin-Protein Ligases chemistry, Solanum lycopersicum immunology, Solanum lycopersicum microbiology, Plant Diseases immunology, Protein Kinases metabolism, Pseudomonas syringae enzymology, Ubiquitin metabolism, Ubiquitin-Protein Ligases metabolism
- Abstract
Many bacterial pathogens of plants and animals use a type III secretion system to deliver diverse virulence-associated 'effector' proteins into the host cell. The mechanisms by which these effectors act are mostly unknown; however, they often promote disease by suppressing host immunity. One type III effector, AvrPtoB, expressed by the plant pathogen Pseudomonas syringae pv. tomato, has a carboxy-terminal domain that is an E3 ubiquitin ligase. Deletion of this domain allows an amino-terminal region of AvrPtoB (AvrPtoB(1-387)) to be detected by certain tomato varieties leading to immunity-associated programmed cell death. Here we show that a host kinase, Fen, physically interacts with AvrPtoB(1-387 )and is responsible for activating the plant immune response. The AvrPtoB E3 ligase specifically ubiquitinates Fen and promotes its degradation in a proteasome-dependent manner. This degradation leads to disease susceptibility in Fen-expressing tomato lines. Various wild species of tomato were found to exhibit immunity in response to AvrPtoB(1-387 )and not to full-length AvrPtoB. Thus, by acquiring an E3 ligase domain, AvrPtoB has thwarted a highly conserved host resistance mechanism.
- Published
- 2007
- Full Text
- View/download PDF
46. Bacterial elicitation and evasion of plant innate immunity.
- Author
-
Abramovitch RB, Anderson JC, and Martin GB
- Subjects
- Animals, Cell Death, Immunity, Innate genetics, Molecular Mimicry, Plant Growth Regulators metabolism, Plants genetics, R Factors genetics, R Factors metabolism, Virulence Factors metabolism, Bacteria immunology, Bacteria pathogenicity, Immunity, Innate physiology, Plant Diseases microbiology, Plants immunology, Plants microbiology
- Abstract
Recent research on plant responses to bacterial attack has identified extracellular and intracellular host receptors that recognize conserved pathogen-associated molecular patterns and more specialized virulence proteins, respectively. These findings have shed light on our understanding of the molecular mechanisms by which bacteria elicit host defences and how pathogens have evolved to evade or suppress these defences.
- Published
- 2006
- Full Text
- View/download PDF
47. Type III effector AvrPtoB requires intrinsic E3 ubiquitin ligase activity to suppress plant cell death and immunity.
- Author
-
Abramovitch RB, Janjusevic R, Stebbins CE, and Martin GB
- Subjects
- Amino Acid Substitution, Apoptosis, Bacterial Proteins chemistry, Bacterial Proteins genetics, Solanum lycopersicum immunology, Lysine chemistry, Lysine genetics, Protein Structure, Tertiary, Pseudomonas syringae metabolism, Two-Hybrid System Techniques, Ubiquitin metabolism, Bacterial Proteins metabolism, Solanum lycopersicum enzymology, Solanum lycopersicum microbiology, Plant Diseases microbiology, Plant Proteins metabolism, Pseudomonas syringae pathogenicity, Ubiquitin-Protein Ligases metabolism
- Abstract
Microbial pathogens of both plants and animals employ virulence factors that suppress the host immune response. The tomato pathogen Pseudomonas syringae injects the AvrPtoB type III effector protein into the plant cell to suppress programmed cell death (PCD) associated with plant immunity. AvrPtoB also inhibits PCD in yeast, indicating that AvrPtoB manipulates a conserved component of eukaryotic PCD. To identify host targets of AvrPtoB, we performed a yeast two-hybrid screen and identified tomato ubiquitin (Ub) as a strong AvrPtoB interactor. AvrPtoB is ubiquitinated in vitro and exhibits E3 Ub ligase activity in the presence of recombinant E1 activating enzyme and specific E2 Ub-conjugating enzymes. The C terminus of AvrPtoB is sufficient for both anti-PCD and E3 Ub ligase activities, suggesting the two functions are associated. Indeed, mutation of AvrPtoB lysine residues in the C terminus, between K512 and K529, disrupts AvrPtoB-Ub interactions, decreases AvrPtoB-mediated anti-PCD activity, and abrogates P. syringae pathogenesis of susceptible tomato plants. Remarkably, quantitative decreases in AvrPtoB anti-PCD activity are correlated with decreases in AvrPtoB ubiquitination and E3 Ub ligase activity. Overall, these data reveal a unique bacterial pathogenesis strategy, where AvrPtoB manipulates the host Ub system and requires intrinsic E3 Ub ligase activity to suppress plant immunity.
- Published
- 2006
- Full Text
- View/download PDF
48. A bacterial inhibitor of host programmed cell death defenses is an E3 ubiquitin ligase.
- Author
-
Janjusevic R, Abramovitch RB, Martin GB, and Stebbins CE
- Subjects
- Bacterial Proteins chemistry, Bacterial Proteins genetics, Humans, Solanum lycopersicum immunology, Molecular Mimicry, Mutagenesis, Plant Diseases microbiology, Plant Leaves metabolism, Plant Leaves microbiology, Plant Proteins, Protein Serine-Threonine Kinases, Protein Structure, Tertiary, Pseudomonas syringae pathogenicity, Recombinant Fusion Proteins genetics, Recombinant Fusion Proteins metabolism, Ubiquitin-Conjugating Enzymes metabolism, Ubiquitin-Protein Ligases genetics, Apoptosis, Bacterial Proteins metabolism, Solanum lycopersicum microbiology, Pseudomonas syringae enzymology, Ubiquitin-Protein Ligases metabolism
- Abstract
The Pseudomonas syringae protein AvrPtoB is translocated into plant cells, where it inhibits immunity-associated programmed cell death (PCD). The structure of a C-terminal domain of AvrPtoB that is essential for anti-PCD activity reveals an unexpected homology to the U-box and RING-finger components of eukaryotic E3 ubiquitin ligases, and we show that AvrPtoB has ubiquitin ligase activity. Mutation of conserved residues involved in the binding of E2 ubiquitin-conjugating enzymes abolishes this activity in vitro, as well as anti-PCD activity in tomato leaves, which dramatically decreases virulence. These results show that Pseudomonas syringae uses a mimic of host E3 ubiquitin ligases to inactivate plant defenses.
- Published
- 2006
- Full Text
- View/download PDF
49. Diverse AvrPtoB homologs from several Pseudomonas syringae pathovars elicit Pto-dependent resistance and have similar virulence activities.
- Author
-
Lin NC, Abramovitch RB, Kim YJ, and Martin GB
- Subjects
- Amino Acid Sequence, Bacterial Proteins genetics, Gene Expression Regulation, Plant, Solanum lycopersicum genetics, Molecular Sequence Data, Plant Leaves microbiology, Plant Proteins genetics, Protein Serine-Threonine Kinases genetics, Pseudomonas syringae classification, Pseudomonas syringae genetics, Pseudomonas syringae metabolism, Sequence Alignment, Nicotiana genetics, Nicotiana metabolism, Two-Hybrid System Techniques, Virulence, Bacterial Proteins chemistry, Bacterial Proteins metabolism, Solanum lycopersicum microbiology, Plant Diseases microbiology, Plant Proteins metabolism, Protein Serine-Threonine Kinases metabolism, Pseudomonas syringae pathogenicity, Sequence Homology, Amino Acid
- Abstract
AvrPtoB is a type III effector protein from Pseudomonas syringae pv. tomato that physically interacts with the tomato Pto kinase and, depending on the host genotype, either elicits or suppresses programmed cell death associated with plant immunity. We reported previously that avrPtoB-related sequences are present in diverse gram-negative phytopathogenic bacteria. Here we describe characterization of avrPtoB homologs from P. syringae pv. tomato T1, PT23, and JL1065, P. syringae pv. syringae B728a, and P. syringae pv. maculicola ES4326. The avrPtoB homolog from P. syringae pv. maculicola, hopPmaL, was identified previously. The four new genes identified in this study are designated avrPtoB(T1), avrPtoB(PT23), avrPtoB(JL1065), and avrPtoB(B728a). The AvrPtoB homologs exhibit 52 to 66% amino acid identity with AvrPtoB. Transcripts of each of the avrPtoB homologs were detected in the Pseudomonas strains from which they were isolated. Proteins encoded by the homologs were detected in all strains except P. syringae pv. tomato T1, suggesting that T1 suppresses accumulation of AvrPtoB(T1). All of the homologs interacted with the Pto kinase in a yeast two-hybrid system and elicited a Pto-dependent defense response when they were delivered into leaf cells by DC3000DeltaavrPtoDeltaavrPtoB, a P. syringae pv. tomato strain with a deletion of both avrPto and avrPtoB. Like AvrPtoB, all of the homologs enhanced the ability of DC3000DeltaavrPtoDeltaavrPtoB to form lesions on leaves of two susceptible tomato lines. With the exception of HopPmaL which lacks the C-terminal domain, all AvrPtoB homologs suppressed programmed cell death elicited by the AvrPto-Pto interaction in an Agrobacterium-mediated transient assay. Thus, despite their divergent sequences, AvrPtoB homologs from diverse P. syringae pathovars have conserved avirulence and virulence activities similar to AvrPtoB activity.
- Published
- 2006
- Full Text
- View/download PDF
50. AvrPtoB: a bacterial type III effector that both elicits and suppresses programmed cell death associated with plant immunity.
- Author
-
Abramovitch RB and Martin GB
- Subjects
- Plant Diseases microbiology, Plant Proteins metabolism, Protein Serine-Threonine Kinases metabolism, Virulence, Apoptosis, Bacterial Proteins metabolism, Gene Expression Regulation, Plant, Immunity, Innate, Solanum lycopersicum microbiology, Pseudomonas syringae pathogenicity
- Abstract
Pseudomonas syringae pv. tomato DC3000 is a model pathogen for studying the molecular basis of plant immunity and disease susceptibility in tomato and Arabidopsis. DC3000 uses a type III secretion system to inject effector proteins into the plant cell. Type III effectors are thought to promote bacterial virulence by suppressing plant defenses and enhancing access to nutrients trapped in the plant cell. The AvrPtoB type III effector elicits immunity-associated programmed cell death (PCD) when expressed in tomato plants carrying the Pto resistance protein. However, in the absence of Pto, AvrPtoB functions to suppress PCD and immunity in tomato. Here, we review current research examining the molecular basis of AvrPtoB-mediated elicitation and suppression of plant PCD. In addition, the "trump model" is proposed to explain how resistance proteins successfully elicit immunity-associated PCD in response to effectors that suppress PCD.
- Published
- 2005
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.